Multiple triggers for NMS.
Gillman
Ken
K
D000210:Acute-Phase Reaction / Q000139:chemically induced / Q000175:diagnosis; D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use / Q000633:toxicity*; D001833:Body Temperature Regulation / Q000187:drug effects; D015984:Causality; D002648:Child; D003430:Cross-Sectional Studies; D004305:Dose-Response Relationship, Drug; D006358:Hot Temperature / Q000009:adverse effects*; D006801:Humans; D018727:Muscarinic Antagonists / Q000627:therapeutic use / Q000633:toxicity; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology*; D012307:Risk Factors; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use / Q000633:toxicity
D014150:Antipsychotic Agents; D018727:Muscarinic Antagonists; D017367:Selective Serotonin Reuptake Inhibitors